医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK1593 医美概念股

午间休市 02-26 12:00:00

1,131.603

-29.320

-2.53%

最高1,164.310	最低1,126.277	成交量3,394万
今开1,160.923	昨收1,160.923	日振幅3.28%
总市值0.00	流通市值0.00	总股本0.00
成交额3.66亿	换手率--	流通股本0.00
市净率1.677197	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"医美概念股","latestPrice":1131.6031,"timestamp":1772078396698,"preClose":1160.9231,"halted":0,"volume":33944210,"delay":0,"changeRate":-0.025256,"floatShares":0,"shares":0,"eps":0,"marketStatus":"午间休市","change":-29.319946,"latestTime":"02-26 12:00:00","open":1160.9231,"high":1164.31,"low":1126.277,"amount":365543824,"amplitude":0.032761,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772082000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1772069400000,1772078400000],[1772082000000,1772092800000]],"pbRate":1.677197,"peRate":24.133483,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK1593","defaultTab":"news","newsList":[{"id":"2614020997","title":"时代天使(06699.HK)拟3月27日举行董事会会议批准年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2614020997","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614020997?lang=zh_cn&edition=full","pubTime":"2026-02-25 17:27","pubTimestamp":1772011624,"startTime":"0","endTime":"0","summary":"格隆汇2月25日丨时代天使(06699.HK)宣布，公司将于2026年3月27日(星期五)举行董事会会议，藉以(其中包括)考虑及批准集团截至2025年12月31日止年度的全年业绩及其刊发及建议的末期股息(如有)，以及处理其他事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260225/32026723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1587","06699","BK1100","BK1583","BK1593"],"gpt_icon":0},{"id":"2614052233","title":"时代天使：董事会召开日期","url":"https://stock-news.laohu8.com/highlight/detail?id=2614052233","media":"香港交易所","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614052233?lang=zh_cn&edition=full","pubTime":"2026-02-25 17:05","pubTimestamp":1772010302,"startTime":"0","endTime":"0","summary":"时代天使科技有限公司宣布，将于2026年3月27日（星期五）召开董事会会议，主要议程包括审议及批准集团截至2025年12月31日止年度之全年业绩、审议业绩公告发布事宜，以及考虑建议之末期股息（如有）等事项。会议将由董事会主席冯岱先生主持，出席会议的董事包括执行董事胡杰章先生、黄琨先生、宋鑫先生及董莉女士，非执行董事冯岱先生，以及独立非执行董事韩小京先生、石子先生及周浩先生。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225191600a71df2af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225191600a71df2af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06699","BK1100","BK1593","BK1587","BK1583"],"gpt_icon":0},{"id":"2614370433","title":"复星医药子公司药品获新增适应症临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2614370433","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614370433?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:50","pubTimestamp":1772009442,"startTime":"0","endTime":"0","summary":"2月25日，复星医药（600196/02196）发布公告，控股子公司复星医药产业近日收到国家药监局关于同意复迈宁?联合安罗替尼用于鼠类肉瘤病毒癌基因（KRAS）突变的晚期非小细胞肺癌患者开展临床试验的批准。复星医药产业计划在条件具备后于中国境内开展该药品的Ⅱ期临床试验。该药品为公司自主研发的创新型小分子化学药物，属于MEK1/2选择性抑制剂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602253654099292.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0012","BK0060","BK0175","BK0183","BK0188","02196","BK0239","BK0196","BK0096","BK1593","BK0028","BK0187","600196","BK1515","BK1191"],"gpt_icon":0},{"id":"2614052225","title":"每日卖空追踪 | 时代天使 02月25日卖空量成交1.06万股，卖空比例为2.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614052225","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614052225?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:30","pubTimestamp":1772008241,"startTime":"0","endTime":"0","summary":"时代天使北京时间02月25日，跌0.13%，卖空量成交1.06万股，较上一交易日减少87.32%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163602a71d5c9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163602a71d5c9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1587","BK1583","06699","BK1593"],"gpt_icon":0},{"id":"2614084149","title":"每日卖空追踪 | 现代牙科 02月25日卖空量成交8000股，卖空比例为1.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614084149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614084149?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:30","pubTimestamp":1772008238,"startTime":"0","endTime":"0","summary":"现代牙科北京时间02月25日，跌1.18%，卖空量成交8000股，较上一交易日减少57.89%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163516a71d5bbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163516a71d5bbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1593","03600","BK1100"],"gpt_icon":0},{"id":"2614039315","title":"每日卖空追踪 | 三生制药 02月25日卖空量成交83.85万股，卖空比例为6.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614039315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614039315?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:30","pubTimestamp":1772008224,"startTime":"0","endTime":"0","summary":"三生制药北京时间02月25日，涨1.08%，卖空量成交83.85万股，较上一交易日减少68.38%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163251a71d590f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163251a71d590f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","BK1583","01530","BK1161","BK1593"],"gpt_icon":0},{"id":"2614055548","title":"每日卖空追踪 | 康哲药业 02月25日卖空量成交27万股，卖空比例为6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614055548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614055548?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:30","pubTimestamp":1772008218,"startTime":"0","endTime":"0","summary":"康哲药业北京时间02月25日，涨1.53%，卖空量成交27万股，较上一交易日减少33.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163149a4c6729c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163149a4c6729c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","LU2488822045.USD","SG9999015945.SGD","IE00BMCWC346.EUR","BK1191","SG9999015986.USD","IE00BYV24P56.USD","IE00BGHQDM52.EUR","00867","SG9999015978.USD","SG9999015952.SGD","SG9999004220.SGD","BK1593"],"gpt_icon":0},{"id":"2614039327","title":"三生制药02月25日主力净流入2323.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2614039327","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614039327?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:15","pubTimestamp":1772007357,"startTime":"0","endTime":"0","summary":"02月25日, 三生制药股价涨1.08%，报收22.54元，成交金额3.0亿元，换手率0.53%，振幅2.51%，量比1.38。三生制药今日主力资金净流入2323.6万元，上一交易日主力净流出1315.0万元。该股近5个交易日下跌3.50%，主力资金累计净流入3589.1万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出4728.4万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225162108a71d4bc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225162108a71d4bc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","BK1583","01530","BK1161","BK1593"],"gpt_icon":0},{"id":"2614068703","title":"丽丰控股盘中异动 下午盘股价大涨15.79%报1.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614068703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614068703?lang=zh_cn&edition=full","pubTime":"2026-02-25 14:20","pubTimestamp":1772000419,"startTime":"0","endTime":"0","summary":"2026年02月25日下午盘14时20分，丽丰控股股票出现波动，股价大幅上涨15.79%。截至发稿，该股报1.100港元/股，成交量400股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出440港元。丽丰控股股票所在的地产投资行业中，整体跌幅为0.26%。其相关个股中，丽丰控股、太和控股、银建国际涨幅较大，振幅较大的相关个股有中国城市基础设施、高山企业、Z FIN，振幅分别为11.25%、8.06%、5.15%。主题公园营运分部于中国内地从事开发及经营主题公园。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225142019a4c5f326&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225142019a4c5f326&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1240","01125","BK1593"],"gpt_icon":0},{"id":"2614877017","title":"复星医药（2196.HK）附属复宏汉霖调整斯鲁利单抗全球授权布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2614877017","media":"IPO投融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614877017?lang=zh_cn&edition=full","pubTime":"2026-02-25 12:26","pubTimestamp":1771993607,"startTime":"0","endTime":"0","summary":"2019年9月30日、2023年8月25日，公司控股子公司复宏汉霖与KGbio先后签订《2019年独家许可协议》《2023年独家许可协议》及《2019年独家许可协议之修正案》，复宏汉霖就许可产品授予KGbio于约定区域及约定领域内的独家商业化及相关权利许可。同日，复宏汉霖与Abbott签订《2024年许可协议之修正案》，就《2024年许可协议》项下约定的许可区域作进一步扩展，并增加相应监管里程碑及销售里程碑付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225131352a4c5bf18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225131352a4c5bf18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000306685.HKD","BK1161","BK1515","HK0000306701.USD","HK0000320223.HKD","HK0000320264.USD","HK0000165453.HKD","BK1191","02196","BK1593","02696"],"gpt_icon":0},{"id":"2614217437","title":"山河药辅：5%以上股东上海复星医药产业发展有限公司减持1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2614217437","media":"公司公告","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614217437?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:50","pubTimestamp":1771944645,"startTime":"0","endTime":"0","summary":"山河药辅 公告，5%以上股东上海 复星医药 产业发展有限公司于2025年11月24日至2026年1月15日以集中竞价交易方式减持股份232.57万股，占总股本1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224225849a4c37e00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224225849a4c37e00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1515","BK1593","BK1191"],"gpt_icon":0},{"id":"1182063591","title":"康哲药业(867.HK/8a8.SG)：磷酸鲁索替尼乳膏新增特应性皮炎适应症上市申请获中国药监局受理并纳入优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=1182063591","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182063591?lang=zh_cn&edition=full","pubTime":"2026-02-24 21:37","pubTimestamp":1771940220,"startTime":"0","endTime":"0","summary":"康哲药业宣布，其磷酸鲁索替尼乳膏用于新增适应症——特应性皮炎（AD）的新药上市申请（NDA），已获得中国国家药品监督管理局的正式受理，并被纳入优先审评程序。这一进展有望加速该产品在中国市场的上市进程，为特应性皮炎患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","IE00BVYPNQ40.USD","BK1593","LU2488822045.USD","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","BK1191","IE00BMCWC346.EUR","SG9999004220.SGD","SG9999015952.SGD","SG9999015986.USD","00867","SG9999015945.SGD","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2613715815","title":"春节假期中缅边境瑞丽口岸出入境旅客逾11万人次","url":"https://stock-news.laohu8.com/highlight/detail?id=2613715815","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613715815?lang=zh_cn&edition=full","pubTime":"2026-02-24 19:52","pubTimestamp":1771933920,"startTime":"0","endTime":"0","summary":"春节假期，瑞丽口岸出入境客流主要以在外中国旅客返乡团圆、出境探亲访友以及缅甸旅客入境观光、体验中国年味为主，客流高峰集中、需求多元多样。2月15日，经该口岸国门通道、中缅街通道出入境旅客突破1.53万人次，创春节期间单日峰值。为精准应对春运客流高峰，瑞丽出入境边防检查站及时发布通关指引、客流预警，开足查验通道，最大限度提升通关效能。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-02-24/doc-inhnxnuk5891157.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-02-24/doc-inhnxnuk5891157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02135","BK1593","BK1209"],"gpt_icon":0},{"id":"2613479416","title":"复星医药（600196）披露控股子公司盐酸莫托咪酯注射液药品注册申请获受理，2月24日股价下跌0.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613479416","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613479416?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:56","pubTimestamp":1771926988,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘，复星医药报收于26.53元，较前一交易日下跌0.15%，最新总市值为708.46亿元。该股当日开盘26.68元，最高26.73元，最低26.51元，成交额达3.26亿元，换手率为0.58%。近日，上海复星医药（集团）股份有限公司控股子公司锦州奥鸿药业有限责任公司提交的盐酸莫托咪酯注射液药品注册申请已获国家药品监督管理局受理，拟定适应症为麻醉诱导和短时手术麻醉。该新药为静脉全身麻醉1类新药，2014年列入“重大新药创制”科技重大专项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400034087.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK1515","BK0188","BK0183","02196","BK0096","BK1593","BK1191","BK0175","BK0187","BK0196","BK0028","BK0012","600196"],"gpt_icon":0},{"id":"1174404047","title":"康哲药业芦可替尼乳膏新增适应症上市申请获受理并纳入优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=1174404047","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174404047?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:54","pubTimestamp":1771926861,"startTime":"0","endTime":"0","summary":"康哲药业宣布，其芦可替尼乳膏新增适应症（特应性皮炎）的上市申请已获中国国家药品监督管理局正式受理，并被纳入优先审评程序。此举有望加速该产品在中国市场的准入进程，为特应性皮炎患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNQ40.USD","BK1191","IE00BVYPNP33.GBP","00867","IE00BYV24P56.USD","BK1593","SG9999015945.SGD","SG9999015952.SGD","SG9999004220.SGD","IE00BMCWC346.EUR","SG9999015978.USD","LU2488822045.USD","IE00BGHQDM52.EUR","SG9999015986.USD"],"gpt_icon":0},{"id":"1125052120","title":"康哲药业芦可替尼磷酸酯乳膏治疗特应性皮炎新药申请获中国国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=1125052120","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125052120?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:49","pubTimestamp":1771926587,"startTime":"0","endTime":"0","summary":"康哲药业宣布，其用于治疗特应性皮炎的芦可替尼磷酸酯乳膏新药申请，已正式获得中国国家药品监督管理局的受理。这一进展标志着该药物在中国上市审批流程中迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNQ40.USD","00867","SG9999015978.USD","SG9999015952.SGD","SG9999015986.USD","BK1191","SG9999015945.SGD","IE00BMCWC346.EUR","IE00BYV24P56.USD","IE00BGHQDM52.EUR","SG9999004220.SGD","BK1593","LU2488822045.USD","IE00BVYPNP33.GBP"],"gpt_icon":0},{"id":"2613871794","title":"康哲药业(00867)：创新药磷酸芦可替尼乳膏增加特应性皮炎(AD)适应症中国上市许可申请获受理并获纳入优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2613871794","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613871794?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:49","pubTimestamp":1771926559,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业 发布公告，旗下德镁医药有限公司已于2026年2月24日获得中国国家药品监督管理局受理磷酸芦可替尼乳膏轻中度特应性皮炎的新药上市许可申请。且该项NDA因“符合儿童生理特征的儿童用药品新品种、剂型和规格”，已获得NMPA药品审评中心批准纳入优先审评品种名单，有望加快产品AD适应症上市审评进程。此次增加AD适应症NDA获受理，是产品向多治疗领域拓展的关键里程碑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BVYPNP33.GBP","BK1161","00867","159992","BK1574","SG9999015986.USD","SG9999015945.SGD","06978","LU2488822045.USD","SG9999015952.SGD","IE00BGHQDM52.EUR","IE00BVYPNQ40.USD","SG9999015978.USD","BK4132","AD","BK1593","BK1191","SG9999004220.SGD","IE00BMCWC346.EUR","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2614735637","title":"医思健康：截至二零二五年三月三十一日止年度年报之补充公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2614735637","media":"香港交易所","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614735637?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:31","pubTimestamp":1771921865,"startTime":"0","endTime":"0","summary":"医思健康发布截至2025年3月31日止年度年报之补充公告，就股份奖励计划作出进一步说明。根据2016年6月27日采纳的股份奖励计划，董事会授出奖励股份的面值不得超过公司已发行股本的10%。于本公告日期，公司并无任何尚未行使或未归属的奖励股份，截至2025年3月31日可供发行的奖励股份总数为1.11亿股。公司强调，未来授出任何奖励股份时将全面遵守上市规则要求，包括不少于12个月的归属期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225023148a71ad52a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225023148a71ad52a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","02138","BK1215","BK1511"],"gpt_icon":0},{"id":"2614874619","title":"医思健康02月24日主力净流出12万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614874619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614874619?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:15","pubTimestamp":1771920927,"startTime":"0","endTime":"0","summary":"02月24日, 医思健康股价跌4.84%，报收0.59元，成交金额59.8万元，换手率0.08%，振幅4.84%，量比4.47。医思健康今日主力资金净流出12万元，上一交易日主力净流出0万元。该股近5个交易日下跌3.23%，主力资金累计净流出12万元；近20日主力资金累计净流出10.1万元，其中净流出天数为2日。该股主力净额占比0.02%，港股市场排名2468/2720。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224161650a7190895&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224161650a7190895&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1215","BK1511","02138","BK1593"],"gpt_icon":0},{"id":"2613752227","title":"时代天使(06699)：欧洲法院对于特定软件功能的初步裁定对用户影响甚微","url":"https://stock-news.laohu8.com/highlight/detail?id=2613752227","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613752227?lang=zh_cn&edition=full","pubTime":"2026-02-24 09:47","pubTimestamp":1771897645,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，时代天使科技有限公司表示，德国杜塞尔多夫统一专利法院下达临时禁令，要求公司暂停使用自动更新方案功能中的特定模块，这对使用时代天使隐形矫治产品的医生和患者影响甚微。时代天使表示，正畸治疗方案设计软件iOrtho中的Live Now功能不存在侵犯爱齐科技任何有效专利的情况。杜塞尔多夫统一专利法院作出的裁定仅为一审，并非最终裁定，时代天使有信心推翻这一裁定。时代天使长期获得医生的高满意度评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406489.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK4585","BK4588","VGT","BK1587","BK1100","BK1583","06699"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":0},{"period":"3month","weight":0.0316},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.162},{"period":"ytd","weight":0.0443}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"name":"BK1593","nameEN":"BK1593"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医美概念股(BK1593)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医美概念股,BK1593,医美概念股股票,医美概念股股票老虎,医美概念股股票老虎国际,医美概念股行情,医美概念股股票行情,医美概念股股价,医美概念股股市,医美概念股股票价格,医美概念股股票交易,医美概念股股票购买,医美概念股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医美概念股(BK1593)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}